Breaking News, Collaborations & Alliances

Crown Bio, Phanes Enter Collaboration

Phanes will gain access to CrownBio’s clinically relevant products to propel their oncology drug discovery pipeline

Crown Bioscience has been selected by Phanes Therapeutics as a strategic partner to advance their oncology drug discovery pipeline.   CrownBio provides the world’s largest collection of Patient-Derived Xenograft (PDX) models and is a leading provider of integrated oncology solutions that enable development of cutting-edge cancer treatments. Phanes will gain access to CrownBio’s clinically relevant CDX models, exclusive PDX models and robust in vitro assays to propel their innovative drug...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters